EP3697818
TREATMENT OF CD20-POSITIVE B-CELL LYMPHOMA WITH OBINUTUZUMAB
:
EP einkaleyfi: Þýðing ekki lögð inn:
19.10.2018:
27.11.2024:
18804720.3
:
18.10.2038
:
TREATMENT OF CD20-POSITIVE B-CELL LYMPHOMA WITH OBINUTUZUMAB
19.10.2018
27.11.2024
:
F. Hoffmann-La Roche AG:
Grenzacherstrasse 124, 4070 Basel, CH
:
WENGER, Michael:
Basel 4070, CH
:
MOBASHER, Mehrdad:
Burlingame, CA 94010, US
:
LIN, Chin-Yu:
South San Francisco, CA 94080-4990, US
:
201762574297 P:
19.10.2017:
US
:
JP2018038924:
19.10.2018
:
C07K 16/28, A61P 35/00, A61K 39/395